Literature DB >> 23550193

Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits.

Cheng Pei1, Yi Xu, Jean Xin Jiang, Li-Jun Cui, Li Li, Li Qin.   

Abstract

AIM: To explore the inhibitory effect of a sustained cyclosporin A (CsA) delivery microsphere (CsA-MS) on posterior capsular opacification (PCO) in rabbit eyes after cataract extraction.
METHODS: Twenty New Zealand white rabbits accepted cataract extraction plus intraocular lens implantation and their left eyes were intraoperatively injected CsA-MS prepared using polymer polylactioglycolic acid (PLGA) as a carrier and their right eyes were injected with empty MS. The changes in cornea, anterior chamber reaction, intraocular pressure, PCO and CsA concentration in aqueous humor were examined postoperatively and all the eyes were enucleated 3 months after surgery for histopathological and morphological examination with light microscopy and electron microscopy.
RESULTS: Conjunctival hyperemia, corneal edema, intraocular pressure and anterior chamber response of experimental and control eyes were similar, while PCO in CsA-MS injected eyes was greatly improved compared with that in control eyes. Posterior capsules in CsA-MS injected eyes were smooth and lens epithelial cells (LEC) did not proliferate significantly (P>0.05), while LEC in posterior capsule of control eyes had different degrees of proliferation and cortical regeneration. LEC in CsA-MS injected eyes were not functionally active and underwent apoptosis, whereas LEC in control eyes were functionally active (F-test, P=0.025). In addition, the corneal ultrastructure showed no differences between CsA-MS and MS injected eyes.
CONCLUSION: CsA-MS has high bioavailability in rabbit eyes and could inhibit postoperative PCO occurrence and development during the study period, suggesting that CsA-MS may be a promising, effective and safe administration route to prevent PCO in clinic.

Entities:  

Keywords:  posterior capsular opacification; rabbit eyes; sustained cyclosporine A delivery microsphere

Year:  2013        PMID: 23550193      PMCID: PMC3580240          DOI: 10.3980/j.issn.2222-3959.2013.01.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  20 in total

1.  In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

Authors:  G T Shin; A Khanna; R Ding; V K Sharma; M Lagman; B Li; M Suthanthiran
Journal:  Transplantation       Date:  1998-02-15       Impact factor: 4.939

2.  Local cyclosporine therapy for experimental autoimmune uveitis in rats.

Authors:  R B Nussenblatt; W J Dinning; L S Fujikawa; C C Chan; A G Palestine
Journal:  Arch Ophthalmol       Date:  1985-10

3.  Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum.

Authors:  M W Mosteller; B M Gebhardt; A M Hamilton; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1985-01

4.  Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery.

Authors:  R Pignatello; C Bucolo; G Puglisi
Journal:  J Pharm Sci       Date:  2002-12       Impact factor: 3.534

5.  Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

Authors:  P Cortina; M J Gómez-Lechón; A Navea; J L Menezo; M C Terencio; M Diaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

6.  Stability and ocular tolerance of cyclophosphamide-loaded nanospheres.

Authors:  A Salgueiro; M A Egea; M Espina; O Valls; M L García
Journal:  J Microencapsul       Date:  2004-03       Impact factor: 3.142

7.  Local efficacy of cyclosporine in corneal transplant therapy.

Authors:  C Oh; A J Apel; B A Saville; Y L Cheng; D S Rootman
Journal:  Curr Eye Res       Date:  1994-05       Impact factor: 2.424

8.  Stimulation of transforming growth factor-beta 1 transcription by cyclosporine.

Authors:  Y Prashar; A Khanna; P Sehajpal; V K Sharma; M Suthanthiran
Journal:  FEBS Lett       Date:  1995-01-23       Impact factor: 4.124

9.  Evaluation of a delivery system providing long-term release of cyclosporine.

Authors:  P A Pearson; G J Jaffe; D F Martin; G J Cordahi; H Grossniklaus; E T Schmeisser; P Ashton
Journal:  Arch Ophthalmol       Date:  1996-03

10.  Ocular penetration of cyclosporin A. III: The human eye.

Authors:  D BenEzra; G Maftzir; C de Courten; P Timonen
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

View more
  4 in total

1.  Bottom-up fabrication of zwitterionic polymer brushes on intraocular lens for improved biocompatibility.

Authors:  Yuemei Han; Xu Xu; Junmei Tang; Chenghui Shen; Quankui Lin; Hao Chen
Journal:  Int J Nanomedicine       Date:  2016-12-20

2.  Rotation versus non-rotation of intraocular lens for prevention of posterior capsular opacification.

Authors:  Rajesh S Joshi; Shrutika A Chavan
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

Review 3.  Posterior Capsule Opacification: A Review of Experimental Studies.

Authors:  Joanna Konopińska; Maryla Młynarczyk; Diana Anna Dmuchowska; Iwona Obuchowska
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

Review 4.  Current Trends in the Pharmacotherapy of Cataracts.

Authors:  Segewkal H Heruye; Leonce N Maffofou Nkenyi; Neetu U Singh; Dariush Yalzadeh; Kalu K Ngele; Ya-Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.